KT
Insider buying
Kevin Tang bought $891K of Fulcrum Therapeutics, Inc. (FULC) stock
Kevin Tang, 10% owner of Fulcrum Therapeutics, Inc. (FULC), bought 249,946 shares of FULC stock worth $891K, per an SEC Form 4 filed Jul 15, 2026.
It was an open-market purchase.
The trade happened on Jul 13, 2026, 2 days before it was made public.
FULC has moved +7.3% since the trade date, from $3.54 to $3.80 (Sep 21, 2026 close).
- Traded
- Jul 13, 2026
- Disclosed
- Jul 15, 2026
- Filing delay
- 2 days
- Price since
- +7.3%
- Role
- 10% owner
- Source
- SEC Form 4
More FULC insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.